| 1 |
Denčić T, Petrović A, Jovičić Milentijević M, Radenković G, Jović M, Živković N, Šalinger S, Branković B, Veličkov A, Ilić I. The Importance of Immunohistochemical Heterogeneous Expression of MMR Protein in Patients with Colorectal Cancer in Stage II and III of the Disease. Medicina 2023;59:489. [DOI: 10.3390/medicina59030489] [Reference Citation Analysis]
|
| 2 |
Aminder S, Saveena J, Ankita S, Harpreet K, Kunal J, Vikram N, Sumit G, Bhavna G, Ramneek K. Histopathological Predictors of Microsatellite Instability in Colorectal Cancer-a Tertiary Care Center Experience. Indian J Surg Oncol 2023;14:137-43. [PMID: 36891442 DOI: 10.1007/s13193-022-01633-4] [Reference Citation Analysis]
|
| 3 |
Nassour AJ, Jain A, Hui N, Siopis G, Symons J, Woo H. Relative Risk of Bladder and Kidney Cancer in Lynch Syndrome: Systematic Review and Meta-Analysis. Cancers (Basel) 2023;15. [PMID: 36672455 DOI: 10.3390/cancers15020506] [Reference Citation Analysis]
|
| 4 |
Ando Y, Kumamoto K, Matsukawa H, Ishikawa R, Suto H, Oshima M, Kamada H, Morishita A, Kobara H, Matsunaga T, Haba R, Masaki T, Suzuki Y, Okano K. Low prevalence of biliary tract cancer with defective mismatch repair genes in a Japanese hospital-based population. Oncol Lett 2022;23:4. [PMID: 34820003 DOI: 10.3892/ol.2021.13122] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 5 |
Yu F, Makrigiorgos A, Leong KW, Makrigiorgos GM. Sensitive detection of microsatellite instability in tissues and liquid biopsies: Recent developments and updates. Comput Struct Biotechnol J 2021;19:4931-40. [PMID: 34527197 DOI: 10.1016/j.csbj.2021.08.037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 6 |
Sugimoto R, Endo M, Osakabe M, Toya Y, Yanagawa N, Matsumoto T, Sugai T. Immunohistochemical Analysis of Mismatch Repair Gene Proteins in Early Gastric Cancer Based on Microsatellite Status. Digestion 2021;102:691-700. [PMID: 33053554 DOI: 10.1159/000510679] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 7 |
Chung C. Predictive and prognostic biomarkers with therapeutic targets in colorectal cancer: A 2021 update on current development, evidence, and recommendation. J Oncol Pharm Pract 2021;:10781552211005525. [PMID: 33832365 DOI: 10.1177/10781552211005525] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 8 |
Leclerc J, Vermaut C, Buisine MP. Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors. Cancers (Basel) 2021;13:467. [PMID: 33530449 DOI: 10.3390/cancers13030467] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 9 |
Akin E, Gonullu E, Altintoprak F. Prophylactic Resections for Genetic Predisposition of Colon and Rectum. Prophylactic Surgery 2021. [DOI: 10.1007/978-3-030-66853-2_19] [Reference Citation Analysis]
|
| 10 |
Diao Z, Han Y, Chen Y, Zhang R, Li J. The clinical utility of microsatellite instability in colorectal cancer. Crit Rev Oncol Hematol 2021;157:103171. [PMID: 33290824 DOI: 10.1016/j.critrevonc.2020.103171] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 11 |
Gilson P, Levy J, Rouyer M, Demange J, Husson M, Bonnet C, Salleron J, Leroux A, Merlin JL, Harlé A. Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers. Sci Rep 2020;10:16386. [PMID: 33009475 DOI: 10.1038/s41598-020-73421-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 12 |
Santoro A, Angelico G, Inzani F, Spadola S, Arciuolo D, Valente M, Musarra T, Capelli G, Fanfani F, Gallotta V, Scambia G, Zannoni GF. Pathological features, immunoprofile and mismatch repair protein expression status in uterine endometrioid carcinoma: focus on MELF pattern of myoinvasion. Eur J Surg Oncol 2021;47:338-45. [PMID: 32788094 DOI: 10.1016/j.ejso.2020.06.041] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 13 |
Bohórquez L ME, Criollo R ÁA, Carvajal Carmona L, Echeverry de Polanco MM. Cáncer de colon en Colombia, fenotipo molecular: tamizaje para síndromes con agregación familiar. RVACCB 2019. [DOI: 10.47499/revistaaccb.v1i31.185] [Reference Citation Analysis]
|
| 14 |
Hacking S, Sajjan S, Angert M, Ebare K, Jin C, Chavarria H, Kataria N, Zhang L, Cho M, Thomas R, Lee L, Nasim M. Tumor Budding in Colorectal Carcinoma Showing a Paradoxical Mitotic Index (Via PHH3) With Possible Association to the Tumor Stromal Microenvironment. Appl Immunohistochem Mol Morphol 2020;28:627-34. [PMID: 31567276 DOI: 10.1097/PAI.0000000000000805] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Hacking S, Jin C, Komforti M, Liang S, Nasim M. MMR deficient undifferentiated/dedifferentiated endometrial carcinomas showing significant programmed death ligand-1 expression (sp 142) with potential therapeutic implications. Pathol Res Pract 2019;215:152552. [PMID: 31353229 DOI: 10.1016/j.prp.2019.152552] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 16 |
Albero-gonzález R, Hernández-llodrà S, Juanpere N, Lorenzo M, Lloret A, Segalés L, Duran X, Fumadó L, Cecchini L, Lloreta-trull J. Immunohistochemical expression of mismatch repair proteins (MSH2, MSH6, MLH1, and PMS2) in prostate cancer: correlation with grade groups (WHO 2016) and ERG and PTEN status. Virchows Arch 2019;475:223-31. [DOI: 10.1007/s00428-019-02591-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 17 |
Yeh YS, Chen YT, Tsai HL, Huang CW, Ma CJ, Su WC, Huang CM, Huang MY, Hu HM, Lu CY, Wang JY. Predictive Value of ERCC1, ERCC2, and XRCC Expression for Patients with Locally Advanced or Metastatic Gastric Cancer Treated with Neoadjuvant mFOLFOX-4 Chemotherapy. Pathol Oncol Res 2020;26:1105-16. [PMID: 31077069 DOI: 10.1007/s12253-019-00666-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 18 |
Sari A, Pollett A, Eiriksson LR, Lumsden-johanson B, Van de Laar E, Kazerouni H, Salehi A, Sur M, Lytwyn A, Ferguson SE. Interobserver Agreement for Mismatch Repair Protein Immunohistochemistry in Endometrial and Nonserous, Nonmucinous Ovarian Carcinomas. American Journal of Surgical Pathology 2019;43:591-600. [DOI: 10.1097/pas.0000000000001220] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 19 |
Markoš P, Brčić I, Brčić L, Jakić-Razumović J, Pulanić R. Microsatellite instability in metaplasia-dysplasia-adenocarcinoma sequence of Barrett esophagus: a retrospective study. Croat Med J 2018;59:100-7. [PMID: 29972732 DOI: 10.3325/cmj.2018.59.100] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
| 20 |
Snowsill T, Coelho H, Huxley N, Jones-Hughes T, Briscoe S, Frayling IM, Hyde C. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation. Health Technol Assess. 2017;21:1-238. [PMID: 28895526 DOI: 10.3310/hta21510] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 11.8] [Reference Citation Analysis]
|
| 21 |
Berho M, Bejarano PA. Rectal cancer and the pathologist. Minerva Chir 2018;73:534-47. [PMID: 29658680 DOI: 10.23736/S0026-4733.18.07739-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 22 |
Heby M, Lundgren S, Nodin B, Elebro J, Eberhard J, Jirström K. Relationship between mismatch repair immunophenotype and long-term survival in patients with resected periampullary adenocarcinoma. J Transl Med 2018;16:66. [PMID: 29540182 DOI: 10.1186/s12967-018-1444-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 23 |
Susanti S, Fadhil W, Ebili HO, Asiri A, Nestarenkaite A, Hadjimichael E, Ham-karim HA, Field J, Stafford K, Matharoo-ball B, Hassall JC, Sharif A, Oniscu A, Ilyas M. N_LyST: a simple and rapid screening test for Lynch syndrome. J Clin Pathol 2018;71:713-20. [DOI: 10.1136/jclinpath-2018-205013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 24 |
Liccardo R, De Rosa M, Duraturo F. Same MSH2 Gene Mutation But Variable Phenotypes in 2 Families With Lynch Syndrome: Two Case Reports and Review of Genotype-Phenotype Correlation. Clin Med Insights Case Rep 2018;11:1179547617753943. [PMID: 29383008 DOI: 10.1177/1179547617753943] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 25 |
Bartosch C, Clarke B, Bosse T. Gynaecological neoplasms in common familial syndromes (Lynch and HBOC). Pathology 2018;50:222-37. [PMID: 29287922 DOI: 10.1016/j.pathol.2017.10.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 26 |
Yeh YS, Chang YT, Ma CJ, Huang CW, Tsai HL, Chen YT, Wang JY. First-decade patient with colorectal cancer carrying both germline and somatic mutations in APC gene. BMC Cancer 2017;17:849. [PMID: 29237421 DOI: 10.1186/s12885-017-3878-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 27 |
Coelho H, Jones-Hughes T, Snowsill T, Briscoe S, Huxley N, Frayling IM, Hyde C. A systematic review of test accuracy studies evaluating molecular micro-satellite instability testing for the detection of individuals with lynch syndrome. BMC Cancer 2017;17:836. [PMID: 29221446 DOI: 10.1186/s12885-017-3820-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 28 |
Jun SY, Lee EJ, Kim MJ, Chun SM, Bae YK, Hong SU, Choi J, Kim JM, Jang KT, Kim JY, Kim GI, Jung SJ, Yoon G, Hong SM. Lynch syndrome-related small intestinal adenocarcinomas. Oncotarget 2017;8:21483-500. [PMID: 28206961 DOI: 10.18632/oncotarget.15277] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 29 |
Cabreira V, Pinto C, Pinheiro M, Lopes P, Peixoto A, Santos C, Veiga I, Rocha P, Pinto P, Henrique R, Teixeira MR. Performance of Lynch syndrome predictive models in quantifying the likelihood of germline mutations in patients with abnormal MLH1 immunoexpression. Fam Cancer 2017;16:73-81. [PMID: 27581132 DOI: 10.1007/s10689-016-9926-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 30 |
Kato A, Sato N, Sugawara T, Takahashi K, Kito M, Makino K, Sato T, Shimizu D, Shirasawa H, Miura H, Sato W, Kumazawa Y, Sato A, Kumagai J, Terada Y. Isolated Loss of PMS2 Immunohistochemical Expression is Frequently Caused by Heterogenous MLH1 Promoter Hypermethylation in Lynch Syndrome Screening for Endometrial Cancer Patients. Am J Surg Pathol 2016;40:770-6. [PMID: 26848797 DOI: 10.1097/PAS.0000000000000606] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 31 |
Jung J, Kang Y, Lee YJ, Kim E, Ahn B, Lee E, Kim JY, Lee JH, Lee Y, Kim CH, Chae YS. Comparison of the Mismatch Repair System between Primary and Metastatic Colorectal Cancers Using Immunohistochemistry. J Pathol Transl Med 2017;51:129-36. [PMID: 28192899 DOI: 10.4132/jptm.2016.12.09] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 32 |
Khan SA, Morris M, Idrees K, Gimbel MI, Rosenberg S, Zeng Z, Li F, Gan G, Shia J, LaQuaglia MP, Paty PB. Colorectal cancer in the very young: a comparative study of tumor markers, pathology and survival in early onset and adult onset patients. J Pediatr Surg 2016;51:1812-7. [PMID: 27558481 DOI: 10.1016/j.jpedsurg.2016.07.015] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 33 |
Vierkoetter KR, Kagami LA, Ahn HJ, Shimizu DM, Terada KY. Loss of Mismatch Repair Protein Expression in Unselected Endometrial Adenocarcinoma Precursor Lesions. Int J Gynecol Cancer 2016;26:228-32. [PMID: 26807560 DOI: 10.1097/IGC.0000000000000606] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 34 |
Bartosch C, Pires-luís AS, Meireles C, Baptista M, Gouveia A, Pinto C, Shannon KM, Jerónimo C, Teixeira MR, Lopes JM, Oliva E. Pathologic Findings in Prophylactic and Nonprophylactic Hysterectomy Specimens of Patients With Lynch Syndrome. American Journal of Surgical Pathology 2016;40:1177-91. [DOI: 10.1097/pas.0000000000000684] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 35 |
Chen YE, Kao SS, Chung RH. Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan. PLoS One 2016;11:e0160599. [PMID: 27482709 DOI: 10.1371/journal.pone.0160599] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 36 |
Sigel C, Cavalcanti MS, Daniel T, Vakiani E, Shia J, Sigel K. Clinicopathologic Features of Colorectal Carcinoma in HIV-Positive Patients. Cancer Epidemiol Biomarkers Prev 2016;25:1098-104. [PMID: 27197294 DOI: 10.1158/1055-9965.EPI-15-1179] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 37 |
Neumann JH, Jung A, Kirchner T. [Molecular pathology of colorectal cancer]. Pathologe 2015;36:137-44. [PMID: 25777075 DOI: 10.1007/s00292-015-0005-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 38 |
Bejarano PA, Garcia-buitrago MT, Berho M, Allende D. Biologic and molecular markers for staging colon carcinoma. Colorectal Cancer 2016;5:41-51. [DOI: 10.2217/crc.15.27] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 39 |
Ladabaum U, Ford JM, Martel M, Barkun AN. American Gastroenterological Association Technical Review on the Diagnosis and Management of Lynch Syndrome. Gastroenterology 2015;149:783-813.e20. [PMID: 26226576 DOI: 10.1053/j.gastro.2015.07.037] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 40 |
Neumann JH, Jung A, Kirchner T. Molekulare Pathologie des kolorektalen Karzinoms. Wien klin Mag 2015;18:140-148. [DOI: 10.1007/s00740-015-0061-6] [Reference Citation Analysis]
|
| 41 |
Bacher JW, Sievers CK, Albrecht DM, Grimes IC, Weiss JM, Matkowskyj KA, Agni RM, Vyazunova I, Clipson L, Storts DR, Thliveris AT, Halberg RB. Improved Detection of Microsatellite Instability in Early Colorectal Lesions. PLoS One 2015;10:e0132727. [PMID: 26252492 DOI: 10.1371/journal.pone.0132727] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 42 |
Snowsill T, Huxley N, Hoyle M, Jones-Hughes T, Coelho H, Cooper C, Frayling I, Hyde C. A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome. Health Technol Assess 2014;18:1-406. [PMID: 25244061 DOI: 10.3310/hta18580] [Cited by in Crossref: 77] [Cited by in F6Publishing: 84] [Article Influence: 9.6] [Reference Citation Analysis]
|
| 43 |
Pectasides D, Karavasilis V, Papaxoinis G, Gourgioti G, Makatsoris T, Raptou G, Vrettou E, Sgouros J, Samantas E, Basdanis G, Papakostas P, Bafaloukos D, Kotoula V, Kalofonos HP, Scopa CD, Pentheroudakis G, Fountzilas G. Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer. BMC Cancer 2015;15:384. [PMID: 25956750 DOI: 10.1186/s12885-015-1406-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 44 |
Hechtman JF, Sadowska J, Huse JT, Borsu L, Yaeger R, Shia J, Vakiani E, Ladanyi M, Arcila ME. AKT1 E17K in Colorectal Carcinoma Is Associated with BRAF V600E but Not MSI-H Status: A Clinicopathologic Comparison to PIK3CA Helical and Kinase Domain Mutants. Mol Cancer Res. 2015;13:1003-1008. [PMID: 25714871 DOI: 10.1158/1541-7786.mcr-15-0062-t] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 45 |
Shia J. Evolving approach and clinical significance of detecting DNA mismatch repair deficiency in colorectal carcinoma. Semin Diagn Pathol 2015;32:352-61. [PMID: 25716099 DOI: 10.1053/j.semdp.2015.02.018] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 46 |
McConechy MK, Talhouk A, Li-Chang HH, Leung S, Huntsman DG, Gilks CB, McAlpine JN. Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas. Gynecol Oncol. 2015;137:306-310. [PMID: 25636458 DOI: 10.1016/j.ygyno.2015.01.541] [Cited by in Crossref: 119] [Cited by in F6Publishing: 129] [Article Influence: 14.9] [Reference Citation Analysis]
|
| 47 |
Yan ZH, Cui LH, Wang XH, Li C, He X. Comparative study of mutations in SNP loci of K-RAS, hMLH1 and hMSH2 genes in neoplastic intestinal polyps and colorectal cancer. World J Gastroenterol 2014; 20(48): 18338-18345 [PMID: 25561800 DOI: 10.3748/wjg.v20.i48.18338] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 48 |
Kushnir VM, Nalbantoglu I, Watson R, Goodwin J, Safar E, Chokshi RV, Azar RR, Davidson NO. Advanced colorectal adenomas in patients under 45 years of age are mostly sporadic. Dig Dis Sci 2014;59:2757-64. [PMID: 24925148 DOI: 10.1007/s10620-014-3245-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 49 |
Boennelycke M, Thomsen BM, Holck S. Sebaceous neoplasms and the immunoprofile of mismatch-repair proteins as a screening target for syndromic cases. Pathol Res Pract 2015;211:78-82. [PMID: 25457183 DOI: 10.1016/j.prp.2014.10.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 50 |
Sun Z, Yu X, Wang H, Zhang S, Zhao Z, Xu R. Clinical significance of mismatch repair gene expression in sporadic colorectal cancer. Exp Ther Med 2014;8:1416-22. [PMID: 25289032 DOI: 10.3892/etm.2014.1927] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 51 |
Cohen SA, Leininger A. The genetic basis of Lynch syndrome and its implications for clinical practice and risk management. Appl Clin Genet. 2014;7:147-158. [PMID: 25161364 DOI: 10.2147/tacg.s51483] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 52 |
Joost P, Veurink N, Holck S, Klarskov L, Bojesen A, Harbo M, Baldetorp B, Rambech E, Nilbert M. Heterogenous mismatch-repair status in colorectal cancer. Diagn Pathol 2014;9:126. [PMID: 24968821 DOI: 10.1186/1746-1596-9-126] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 53 |
Okkels H, Lindorff-Larsen K, Thorlasius-Ussing O, Vyberg M, Lindebjerg J, Sunde L, Bernstein I, Klarskov L, Holck S, Krarup HB. MSH6 mutations are frequent in hereditary nonpolyposis colorectal cancer families with normal pMSH6 expression as detected by immunohistochemistry. Appl Immunohistochem Mol Morphol. 2012;20:470-477. [PMID: 22495361 DOI: 10.1097/PAI.0b013e318249739b] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 54 |
Lu F, Gilks CB, Mulligan A, Ryan P, Allo G, Sy K, Shaw PA, Pollett A, Clarke BA. Prevalence of Loss of Expression of DNA Mismatch Repair Proteins in Primary Epithelial Ovarian Tumors: . International Journal of Gynecological Pathology 2012;31:524-31. [DOI: 10.1097/pgp.0b013e31824fe2aa] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 55 |
Chen HJ, Lin Q, Zeng L, Yang BL. Recent advances in molecular diagnosis of hereditary nonpolyposis colorectal cancer. Shijie Huaren Xiaohua Zazhi 2012; 20(29): 2806-2811 [DOI: 10.11569/wcjd.v20.i29.2806] [Reference Citation Analysis]
|
| 56 |
Jung SB, Lee HI, Oh HK, Shin IH, Jeon CH. Clinico-pathologic Parameters for Prediction of Microsatellite Instability in Colorectal Cancer. Cancer Res Treat. 2012;44:179-186. [PMID: 23091444 DOI: 10.4143/crt.2012.44.3.179] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 57 |
Salo-mullen EE, Guillem JG. The Genetic Counselor. Advances in Surgery 2012;46:137-53. [DOI: 10.1016/j.yasu.2012.03.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 58 |
Neumann J, Reu S, Kirchner T. [Prognostic marker profiles for risk of distant metastases in colorectal cancer]. Pathologe 2012;33:39-44. [PMID: 22293788 DOI: 10.1007/s00292-011-1543-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 59 |
Walsh MD, Buchanan DD, Pearson SA, Clendenning M, Jenkins MA, Win AK, Walters RJ, Spring KJ, Nagler B, Pavluk E, Arnold ST, Goldblatt J, George J, Suthers GK, Phillips K, Hopper JL, Jass JR, Baron JA, Ahnen DJ, Thibodeau SN, Lindor N, Parry S, Walker NI, Rosty C, Young JP. Immunohistochemical testing of conventional adenomas for loss of expression of mismatch repair proteins in Lynch syndrome mutation carriers: a case series from the Australasian site of the colon cancer family registry. Mod Pathol 2012;25:722-30. [PMID: 22322191 DOI: 10.1038/modpathol.2011.209] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 60 |
Kumari N, Kapoor VK, Krishnani N, Kumar K, Kumar Baitha D, Behari A. Microsatellite instability and loss of fragile histidine triad in gallbladder carcinoma. Basic and Applied Pathology 2012;5:1-7. [DOI: 10.1111/j.1755-9294.2012.01123.x] [Reference Citation Analysis]
|
| 61 |
Yurgelun MB, Goel A, Hornick JL, Sen A, Turgeon DK, Ruffin MT 4th, Marcon NE, Baron JA, Bresalier RS. Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps. Cancer Prev Res (Phila). 2012;5:574-582. [PMID: 22262812 DOI: 10.1158/1940-6207.capr-11-0519] [Cited by in Crossref: 83] [Cited by in F6Publishing: 85] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 62 |
Petersson F, Šíma R, Sperga M, Kazakov DV, Michal M, Hora M, Ferda J, Šulc M, Mičulka P, Haferník J, Rychnovský J, Hes O. Lymphocyte-rich Renal Cell Carcinoma: An Unusual Histomorphologic Manifestation of a Tumor That is not Part of Lynch Syndrome. Applied Immunohistochemistry & Molecular Morphology 2011;19:519-27. [DOI: 10.1097/pai.0b013e31821a931f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 63 |
Warrier SK, Trainer AH, Lynch AC, Mitchell C, Hiscock R, Sawyer S, Boussioutas A, Heriot AG. Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy. Dis Colon Rectum 2011;54:1480-7. [PMID: 22067175 DOI: 10.1097/DCR.0b013e318231db1f] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 64 |
Schofield L, Grieu F, Goldblatt J, Amanuel B, Iacopetta B. A state-wide population-based program for detection of lynch syndrome based upon immunohistochemical and molecular testing of colorectal tumours. Familial Cancer 2012;11:1-6. [DOI: 10.1007/s10689-011-9494-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 65 |
Luévano-González A, Guzmán AQ, Ancer Rodríguez J, Ortiz López R, Rojas Martínez A, González Guerrero JF, Flores Gutiérrez JP. Analysis of DNA mismatch repair proteins expression and BRAF V600E mutation in a subset of early- and late-onset colorectal carcinoma patients in Mexico. Arch Med Res 2011;42:457-62. [PMID: 21945875 DOI: 10.1016/j.arcmed.2011.09.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 66 |
Mojtahed A, Schrijver I, Ford JM, Longacre TA, Pai RK. A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal carcinomas, skin sebaceous tumors, and gynecologic tract carcinomas. Mod Pathol 2011;24:1004-14. [PMID: 21499234 DOI: 10.1038/modpathol.2011.55] [Cited by in Crossref: 84] [Cited by in F6Publishing: 86] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 67 |
Lee KH, Lee JS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Lee JH. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence. Langenbecks Arch Surg. 2011;396:1017-1026. [PMID: 21706233 DOI: 10.1007/s00423-011-0812-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 68 |
Puppa G. TNM staging system of colorectal carcinoma: surgical pathology of the seventh edition. Diagnostic Histopathology 2011;17:243-62. [DOI: 10.1016/j.mpdhp.2011.03.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 69 |
Gallagher DJ, Smith JD, Offit K, Stadler ZK. Diagnosing hereditary colorectal cancer. Clin Colorectal Cancer 2010;9:205-11. [PMID: 20920991 DOI: 10.3816/CCC.2010.n.030] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 70 |
Radu OM, Nikiforova MN, Farkas LM, Krasinskas AM. Challenging cases encountered in colorectal cancer screening for Lynch syndrome reveal novel findings: nucleolar MSH6 staining and impact of prior chemoradiation therapy. Hum Pathol 2011;42:1247-58. [PMID: 21334712 DOI: 10.1016/j.humpath.2010.11.016] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 71 |
Devlin LA, Morrison PJ. Inherited gynaecological cancer syndromes. The Obstetrician & Gynaecologist 2008;10:9-15. [DOI: 10.1576/toag.10.1.009.27371] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 72 |
Barrow E, Evans DG, Mcmahon R, Hill J, Byers R. A comparative study of quantitative immunohistochemistry and quantum dot immunohistochemistry for mutation carrier identification in Lynch syndrome. J Clin Pathol 2011;64:208-14. [DOI: 10.1136/jcp.2010.084418] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 73 |
Kumarasinghe AP, de Boer B, Bateman AC, Kumarasinghe MP. DNA mismatch repair enzyme immunohistochemistry in colorectal cancer: a comparison of biopsy and resection material. Pathology. 2010;42:414-420. [PMID: 20632816 DOI: 10.3109/00313025.2010.493862] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 74 |
Iacopetta B, Grieu F, Amanuel B. Microsatellite instability in colorectal cancer. Asia Pac J Clin Oncol. 2010;6:260-269. [PMID: 21114775 DOI: 10.1111/j.1743-7563.2010.01335.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 54] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 75 |
Cossio SL, Koehler-Santos P, Pessini SA, Mónego H, Edelweiss MI, Meurer L, Errami A, Coffa J, Bock H, Saraiva-Pereira ML, Ashton-Prolla P, Prolla JC. Clinical and histomolecular endometrial tumor characterization of patients at-risk for Lynch syndrome in South of Brazil. Fam Cancer 2010;9:131-9. [PMID: 19821155 DOI: 10.1007/s10689-009-9297-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 76 |
Barrow E, Jagger E, Brierley J, Wallace A, Evans G, Hill J, McMahon R. Semiquantitative assessment of immunohistochemistry for mismatch repair proteins in Lynch syndrome. Histopathology 2010;56:331-44. [PMID: 20459533 DOI: 10.1111/j.1365-2559.2010.03485.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 77 |
Klarskov L, Ladelund S, Holck S, Roenlund K, Lindebjerg J, Elebro J, Halvarsson B, von Salomé J, Bernstein I, Nilbert M. Interobserver variability in the evaluation of mismatch repair protein immunostaining. Hum Pathol 2010;41:1387-96. [PMID: 20573374 DOI: 10.1016/j.humpath.2010.03.003] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 78 |
Agaram NP, Shia J, Tang LH, Klimstra DS. DNA mismatch repair deficiency in ampullary carcinoma: a morphologic and immunohistochemical study of 54 cases. Am J Clin Pathol 2010;133:772-80. [PMID: 20395525 DOI: 10.1309/AJCPGDDE8PLLDRCC] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 79 |
Meijer TW, Hoogerbrugge N, Nagengast FM, Ligtenberg MJ, van Krieken JH. In Lynch syndrome adenomas, loss of mismatch repair proteins is related to an enhanced lymphocytic response. Histopathology 2009;55:414-22. [PMID: 19817892 DOI: 10.1111/j.1365-2559.2009.03403.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 80 |
Shia J, Tang LH, Vakiani E, Guillem JG, Stadler ZK, Soslow RA, Katabi N, Weiser MR, Paty PB, Temple LK, Nash GM, Wong WD, Offit K, Klimstra DS. Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel. Am J Surg Pathol. 2009;33:1639-1645. [PMID: 19701074 DOI: 10.1097/pas.0b013e3181b15aa2] [Cited by in Crossref: 122] [Cited by in F6Publishing: 129] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 81 |
Martin L, Coffey M, Lawler M, Hollywood D, Marignol L. DNA mismatch repair and the transition to hormone independence in breast and prostate cancer. Cancer Lett 2010;291:142-9. [PMID: 19896265 DOI: 10.1016/j.canlet.2009.10.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 82 |
Khanifar E, Stamos MJ, Billings TL, Wu ML. Contemporary Evaluation of Colorectal Carcinoma in Specimens from Endoscopic Biopsies. Lab Med 2009;40:617-24. [DOI: 10.1309/lm8trjp8jy7sstsu] [Reference Citation Analysis]
|
| 83 |
Pino MS, Mino-Kenudson M, Wildemore BM, Ganguly A, Batten J, Sperduti I, Iafrate AJ, Chung DC. Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas. J Mol Diagn 2009;11:238-47. [PMID: 19324997 DOI: 10.2353/jmoldx.2009.080142] [Cited by in Crossref: 81] [Cited by in F6Publishing: 81] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 84 |
Schofield L, Watson N, Grieu F, Li WQ, Zeps N, Harvey J, Stewart C, Abdo M, Goldblatt J, Iacopetta B. Population-based detection of Lynch syndrome in young colorectal cancer patients using microsatellite instability as the initial test. Int J Cancer 2009;124:1097-102. [PMID: 19072991 DOI: 10.1002/ijc.23863] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 85 |
Resnick K, Cohn D. Ovarian and Endometrial Cancer in Patients with Hereditary Non-polyposis Colorectal Cancer Syndrome. The Role of Genetics in Breast and Reproductive Cancers 2009. [DOI: 10.1007/978-1-4419-0477-5_8] [Reference Citation Analysis]
|
| 86 |
Sanchez JA, Vogel JD, Kalady MF, Bronner MP, Skacel M, Church JM. Identifying Lynch syndrome: we are all responsible. Dis Colon Rectum 2008;51:1750-6. [PMID: 18682882 DOI: 10.1007/s10350-008-9414-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 87 |
Bujalkova M, Zavodna K, Krivulcik T, Ilencikova D, Wolf B, Kovac M, Karner-Hanusch J, Heinimann K, Marra G, Jiricny J, Bartosova Z. Multiplex SNaPshot genotyping for detecting loss of heterozygosity in the mismatch-repair genes MLH1 and MSH2 in microsatellite-unstable tumors. Clin Chem 2008;54:1844-54. [PMID: 18772310 DOI: 10.1373/clinchem.2008.108902] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 88 |
Shia J. Immunohistochemistry vs microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. J Mol Diagn. 2008;10:293-300. [PMID: 18556767 DOI: 10.2353/jmoldx.2008.080031] [Cited by in Crossref: 421] [Cited by in F6Publishing: 457] [Article Influence: 28.1] [Reference Citation Analysis]
|
| 89 |
Yan HL, Hao LQ, Jin HY, Xing QH, Xue G, Mei Q, He J, He L, Sun SH. Clinical features and mismatch repair genes analyses of Chinese suspected hereditary non-polyposis colorectal cancer: a cost-effective screening strategy proposal. Cancer Sci. 2008;99:770-780. [PMID: 18307539 DOI: 10.1111/j.1349-7006.2008.00737.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 90 |
Chen JR, Chiang JM, Changchien CR, Chen JS, Tang RP, Wang JY. Mismatch repair protein expression in Amsterdam II criteria-positive patients in Taiwan. Br J Surg 2008;95:102-10. [PMID: 18064717 DOI: 10.1002/bjs.5786] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 91 |
Shia J, Black D, Hummer AJ, Boyd J, Soslow RA. Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer. Hum Pathol. 2008;39:116-125. [PMID: 17949789 DOI: 10.1016/j.humpath.2007.05.022] [Cited by in Crossref: 122] [Cited by in F6Publishing: 127] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 92 |
Watson N, Grieu F, Morris M, Harvey J, Stewart C, Schofield L, Goldblatt J, Iacopetta B. Heterogeneous staining for mismatch repair proteins during population-based prescreening for hereditary nonpolyposis colorectal cancer. J Mol Diagn 2007;9:472-8. [PMID: 17652638 DOI: 10.2353/jmoldx.2007.060162] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 93 |
Modica I, Soslow RA, Black D, Tornos C, Kauff N, Shia J. Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma. Am J Surg Pathol 2007;31:744-51. [PMID: 17460459 DOI: 10.1097/01.pas.0000213428.61374.06] [Cited by in Crossref: 103] [Cited by in F6Publishing: 107] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 94 |
Guillem JG, Glogowski E, Moore HG, Nafa K, Markowitz AJ, Shia J, Offit K, Ellis NA. Single-amplicon MSH2 A636P mutation testing in Ashkenazi Jewish patients with colorectal cancer: role in presurgical management. Ann Surg 2007;245:560-5. [PMID: 17414604 DOI: 10.1097/01.sla.0000252589.26244.d4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 95 |
Iacopetta B, Platell C. POPULATION-BASED SCREENING FOR HEREDITARY NON-POLYPOSIS COLORECTAL CANCER (LYNCH SYNDROME): THE WESTERN AUSTRALIAN APPROACH. ANZ J Surg 2007;77:197-198. [DOI: 10.1111/j.1445-2197.2007.04017.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 96 |
Bernstein H, Prasad A, Holubec H, Bernstein C, Payne CM, Ramsey L, Dvorakova K, Wilson M, Warneke JA, Garewal H. Reduced Pms2 expression in non-neoplastic flat mucosa from patients with colon cancer correlates with reduced apoptosis competence. Appl Immunohistochem Mol Morphol 2006;14:166-72. [PMID: 16785784 DOI: 10.1097/01.pai.0000170533.61579.b9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 97 |
Bendardaf R, Lamlum H, Ristamäki R, Korkeila E, Syrjänen K, Pyrhönen S. Mismatch Repair Status Is a Predictive Factor of Tumour Response to 5-Fluorouracil and Irinotecan Chemotherapy in Patients with Advanced Colorectal Cancer. Tumor Biol 2007;28:212-20. [DOI: 10.1159/000107417] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 98 |
Guillem JG, Wood WC, Moley JF, Berchuck A, Karlan BY, Mutch DG, Gagel RF, Weitzel J, Morrow M, Weber BL, Giardiello F, Rodriguez-Bigas MA, Church J, Gruber S, Offit K. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. Ann Surg Oncol. 2006;13:1296-1321. [PMID: 16990987 DOI: 10.1245/s10434-006-9036-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 99 |
Guillem JG, Wood WC, Moley JF, Berchuck A, Karlan BY, Mutch DG, Gagel RF, Weitzel J, Morrow M, Weber BL. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Clin Oncol. 2006;24:4642-4660. [PMID: 17008706 DOI: 10.1200/jco.2005.04.5260] [Cited by in Crossref: 163] [Cited by in F6Publishing: 174] [Article Influence: 9.6] [Reference Citation Analysis]
|
| 100 |
Lassmann S, Werner M. A commentary on the article "Prevalence of the mismatch repair-deficient phenotype in colonic adenomas arising in HNPCC patients--results of a 5-year follow-up study". Int J Colorectal Dis 2006;21:642-4. [PMID: 16468030 DOI: 10.1007/s00384-005-0081-6] [Reference Citation Analysis]
|
| 101 |
Chen S, Wang W, Lee S, Nafa K, Lee J, Romans K, Watson P, Gruber SB, Euhus D, Kinzler KW, Jass J, Gallinger S, Lindor NM, Casey G, Ellis N, Giardiello FM, Offit K, Parmigiani G; Colon Cancer Family Registry. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 2006;296:1479-87. [PMID: 17003396 DOI: 10.1001/jama.296.12.1479] [Cited by in Crossref: 274] [Cited by in F6Publishing: 293] [Article Influence: 16.1] [Reference Citation Analysis]
|
| 102 |
Bouzourene H, Taminelli L, Chaubert P, Monnerat C, Seelentag W, Sandmeier D, Andrejevic S, Matter M, Bosman F, Benhattar J. A Cost-Effective Algorithm for Hereditary Nonpolyposis Colorectal Cancer Detection. Am J Clin Pathol 2006;125:823-31. [DOI: 10.1309/b0afdt52etmkejbe] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 103 |
Goldstein NS. The Gray Area Between Heritable and Cancer Somatic (Tumor Phenotype) Molecular Genetic Testing of Colorectal Adenocarcinomas: It Depends on the End Point. Am J Clin Pathol 2006;125:813-4. [DOI: 10.1309/jx4q8fjtpj033kge] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 104 |
Funaioli C, Pinto C, Mutri V, Di Fabio F, Ceccarelli C, Angelo Martoni A. Does Biomolecular Characterization of Stage II/III Colorectal Cancer Have Any Prognostic Value? Clinical Colorectal Cancer 2006;6:38-45. [DOI: 10.3816/ccc.2006.n.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 105 |
Mangold E, Pagenstecher C, Friedl W, Fischer HP, Merkelbach-Bruse S, Ohlendorf M, Friedrichs N, Aretz S, Buettner R, Propping P. Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining. J Pathol. 2005;207:385-395. [PMID: 16216036 DOI: 10.1002/path.1858] [Cited by in Crossref: 77] [Cited by in F6Publishing: 78] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 106 |
Ward RL, Turner J, Williams R, Pekarsky B, Packham D, Velickovic M, Meagher A, O'connor T, Hawkins NJ. Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified. J Pathol 2005;207:377-84. [DOI: 10.1002/path.1851] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 107 |
Rakheja D, Kapur P, Tomlinson GE, Margraf LR. Pediatric renal cell carcinomas with Xp11.2 rearrangements are immunoreactive for hMLH1 and hMSH2 proteins. Pediatr Dev Pathol 2005;8:615-20. [PMID: 16328670 DOI: 10.1007/s10024-005-0148-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 108 |
Axell L, Ahnen D, Markey K. Basic concepts for genetic testing in common hereditary colorectal cancer syndromes. Curr colorectal cancer rep 2005;1:73-84. [DOI: 10.1007/s11888-005-0003-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 109 |
Della Giovanna P, Cabrera H. Síndromes cutáneos con poliposis intestinal. Piel 2005;20:231-242. [DOI: 10.1016/s0213-9251(05)72268-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 110 |
Terdiman JP. Colorectal cancer at a young age. Gastroenterology 2005;128:1067-76. [PMID: 15825087 DOI: 10.1053/j.gastro.2005.02.055] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
